Clinical Research & Trials
Contributing to global medical knowledge through extensive research and evidence-based medicine.
Advancing medicine beyond the consultation room through clinical research, evidence generation and global collaboration.
As Principal Investigator for major multinational clinical outcomes trials, Prof. Murthy's research informs treatment protocols and shapes the future of metabolic and cardiovascular medicine worldwide.
Landmark Studies
Participation in over 85 clinical trials including randomized double-blind trials, placebo-controlled trials, outcomes trials, and post-marketing surveillance studies.
Diabetes Therapy Innovations
Investigating novel therapeutic approaches for diabetes management including new drug classes and treatment protocols.
Basal & Weekly Insulin Analogs
Evaluating the efficacy and safety of next-generation insulin formulations for improved glycemic control.
Cardiovascular Outcomes
Studying cardiovascular outcomes in patients with diabetes and metabolic syndrome.
Renal Impairment Progression
Investigating renal outcomes and progression markers in diabetic kidney disease.
Hypertension Management
Research into optimal approaches for managing hypertension in patients with metabolic conditions.
Digital Twin Technology
Exploring digital twin technology applications in diabetes remission and personalized medicine.
Research Contributions
International Journals
- The Lancet
- Diabetes, Obesity & Metabolism
- Advanced Therapeutics
- Clinical Diabetes
- Journal of the American College of Cardiology (JACC)
National Journals
- Indian Journal of Endocrinology & Metabolism
- JAPI
- Heart India
- Indian Heart Journal
Textbook Contributions
- API Critical Care Textbook
- "Comorbidities of Diabetes"
- RSSDI Update Book 2020
- RSSDI Textbook of Diabetes Mellitus
Leading Research at Scale
As National Lead Investigator for renowned global outcome trials, Prof. Murthy contributes to evidence that shapes treatment guidelines and clinical practice across multiple countries.
The research portfolio spans randomized controlled trials, outcomes studies, and post-marketing surveillance, covering the full spectrum of metabolic, cardiovascular, and renal medicine.
Research Inquiries